Advancing transparency in RWE and epidemiological studies: an interview with Jesse Berlin

In this interview, following his involvement in the publication of STaRT-RWE, a structured template tool for the planning and reporting on real-world evidence (RWE) study implementation, Jesse Berlin, Vice President and Global Head of Epidemiology for Johnson & Johnson (PA, USA), discusses challenges associated with working with real-world and epidemiologic data, as well as how we may help advance transparency in the context of studies utilizing these. Please could you introduce yourself, your organization and give a brief overview of your career to date? I currently serve as Vice President and Global Head of Epidemiology for Johnson & Johnson. After...